🔎 Trials Near Me

Inicio › Enfermedad de células falciformes › Maryland

Ensayos clínicos de Enfermedad de células falciformes en Maryland

17 estudios sobre Enfermedad de células falciformes buscan participantes en Maryland.

Ciudades en Maryland

Texto oficial del estudio (inglés)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • The Johns Hopkins University School of Medicine, Baltimore
ReclutandoFase 3
Edades de 12 a 100 · Todos los sexos · Actualizado el 10 nov 2026 · NCT06439082

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1
Edades de 18 a 65 · Todos los sexos · Actualizado el 5 nov 2026 · NCT05904093

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Center for Cancer and Blood Disorders, Bethesda
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07224360

Blood Sampling for Research Related to Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 100 · Todos los sexos · Actualizado el 26 oct 2026 · NCT00542230

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1
Edades de 18 a 90 · Todos los sexos · Actualizado el 21 oct 2026 · NCT07566494

Virtual Reality for SCD VOC

  • University of Maryland Medical Center, Stoler Infusion Center, Baltimore
Reclutando
Edades de 18 a 88 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07674277

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • University of Maryland School of Medicine - Baltimore- Site Number : 8400041, Baltimore
ReclutandoFase 3
Edades de 10 a 65 · Todos los sexos · Actualizado el 15 oct 2026 · NCT06975865

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

  • National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2
Edades de 4 a 65 · Todos los sexos · Actualizado el 13 oct 2026 · NCT07599176

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • University of Maryland, Baltimore
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT06699849

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

  • National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 70 · Todos los sexos · Actualizado el 2 oct 2026 · NCT03937817

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

  • National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1 temprana
Edades de 18 a 100 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06313398

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 a 120 · Todos los sexos · Actualizado el 18 sept 2026 · NCT05170412

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 2 a 99 · Todos los sexos · Actualizado el 11 sept 2026 · NCT06944067

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

  • National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06442761

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Local Institution - 0064, Baltimore
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Johns Hopkins University Hemophilia Treatment Center, Baltimore
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 17 ago 2026 · NCT04398628

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

  • University of Maryland Medical Systems, Baltimore
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 dic 2025 · NCT06184126

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.